NDH.com

icon


Wolters Kluwer | Lippincott Williams & Wilkins
Drug Updates | New Indications
orange bar


   Web Toolkit

   Drug Updates
       New Drugs
       New Indications
   Patient Teaching

   News Capsules

   Drug Warnings

   Herbal Spotlight

   Drug Info and
   Nursing Links


   CE Tests

   Career Opportunities

   Drug Info Bookstore

   Feedback

   Registration

   Disclaimer



bevacizumab
Avastin Pharmaceutical company:
Genentech
www.gene.com

NEW INDICATION & DOSAGE
Metastatic renal cell carcinoma—
Adults: 10 mg/kg as I.V. infusion every 2 weeks in combination with interferon alfa. Infuse first infusion over 90 minutes; if first infusion is tolerated, administer second infusion over 60 minutes; all subsequent infusions can be given over 30 minutes if infusion over 60 minutes is tolerated.

     
   

Home - Guest Registry - Customer Service

Brought to you by Lippincott Williams & Wilkins.
For help on how you should use this site, see our
Disclaimer .

© Copyright 2010 by Lippincott Williams & Wilkins